| Name | Number of Reports | Reference(s) | Data Source | |
|---|---|---|---|---|
| 1 | reviparin | FAERS: 22 | US FAERS | |
| 2 | Bortezomib | FAERS: 4 | US FAERS | |
| 3 | Imatinib Mesylate | FAERS: 3 | US FAERS | |
| 4 | NuvaRing | FAERS: 3 | US FAERS | |
| 5 | Aztreonam | FAERS: 2 | SIDER US FAERS | |
| 6 | Cefotetan | FAERS: 2 | US FAERS | |
| 7 | Citalopram | FAERS: 2 | US FAERS | |
| 8 | Moxifloxacin | FAERS: 2 | US FAERS | |
| 9 | Arthrotec | FAERS: 1 | US FAERS | |
| 10 | Bendamustine Hydrochloride | FAERS: 1 | US FAERS | |
| 11 | Deferasirox | FAERS: 1 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 12 | Everolimus | FAERS: 1 | US FAERS | |
| 13 | Indapamide | FAERS: 1 | US FAERS | |
| 14 | Lenalidomide | FAERS: 1 | US FAERS | |
| 15 | Medroxyprogesterone Acetate | FAERS: 1 | US FAERS | |
| 16 | Meropenem | FAERS: 1 | US FAERS | |
| 17 | Methimazole | FAERS: 1 | US FAERS | |
| 18 | Rivaroxaban | FAERS: 1 | US FAERS | |
| 19 | Ruxolitinib phosphate | FAERS: 1 | US FAERS | |
| 20 | Sertraline | FAERS: 1 | US FAERS | |
| 21 | Sulfasalazine | FAERS: 1 | US FAERS | |
| 22 | carfilzomib | FAERS: 1 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 23 | eltrombopag | FAERS: 1 | US FAERS | |
| 24 | fludarabine | FAERS: 1 | US FAERS | |
| 25 | regorafenib | FAERS: 1 | US FAERS | |
| 26 | Cefixime | SIDER | ||
| 27 | Ceftazidime | SIDER | ||
| 28 | Ceftizoxime | SIDER | ||
| 29 | Cefuroxime | SIDER | ||
| 30 | Clonidine | SIDER | ||
| 31 | Methyldopa | SIDER |
Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120240
Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.